Blog & Web Directory on India
    
Advertise    SI Web Directory    Home    About Us     Facebook    Twitter
 
Share

In an age of $400 iPods, $300 iPhones and $200 Nikes, nobody gives a flying f*@# for a bicycle anymore.

Not even a desperate Italian thief.

But there was a time and day in Italy – in the not too distant past – when a bicycle was a big draw for a thief in Italy.

Those were the years following the end of World War II. Italy had ended up on the loser’s side in the second big war.

Both the country and its people were in dire straits. Food and jobs were scarce. And the mood was desolate for most Italians.

This grim setting provides the backdrop for The Bicycle Thief made by acclaimed director Vittorio de Sica in 1948.

The story is simple. Yet so arrestingly moving.

It’s the story of a poor family man Antonio Ricci (Lamberto Maggiorani) in Rome whose wife Maria (Lianell Carell) sells the sheets on the beds in their home to buy a bicycle. You see, one of the key conditions of Antonio’s new job – pasting flyers on the walls – is that he must have a bicycle.

No sooner does Antonio get a used bicycle than he quickly loses it. On the Continue reading »

Share
 
Share

Showing the middle finger to Swedish IT workers, Ericsson has inked a five-year contract with India’s Tata Consultancy Services to provide application maintenance and development services for Ericsson’s internal IT operations.

Like their American counterparts, Nordic companies are increasingly hopping on to the outsourcing bandwagon.

The value of the contract was not disclosed.

Share
 
Share

Citing “serious manufacturing deficiencies” at plants belonging to Indian drug manufacturer Ranbaxy, the U.S. Food and Drug Administration has banned import of over 30 different generic drugs from the company.

The Ranbaxy plants under fire are located at Dewas and Paonta Sahib in India.

The FDA also sent out two warning letters to Ranbaxy, the second time the agency has issued a warning letter to this company in less than three years.

According to FDA oficials, the problems at the two Ranbaxy plants relate to deficiencies in the company’s drug manufacturing process including inadequate sterile processing operations, cleaning of equipment used to make drugs, cross-contamination concerns and quality control issues.

The ban excludes Ganciclovir oral capsules because Ranbaxy is the sole supplier of this drug to the U.S.

So if you live in the U.S. (like we do), you might want to think twice before taking any Ranbaxy drugs. Given the high cost of healthcare in the U.S., you just can’t afford to take chances (Apart from the FDA’s serious concerns, Ranbaxy is also being investigated separately by the U.S. Justice Department). 

According to the FDA’s director of its Center for Drug Evaluation and Continue reading »

Share
© 2012 SearchIndia.com   Privacy Policy Suffusion theme by Sayontan Sinha